GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Implantica AG (OSTO:IMP A SDB) » Definitions » FCF Margin %

Implantica AG (OSTO:IMP A SDB) FCF Margin % : 0.00% (As of . 20)


View and export this data going back to 2020. Start your Free Trial

What is Implantica AG FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Implantica AG's Free Cash Flow for the six months ended in . 20 was kr0.00 Mil. Implantica AG's Revenue for the six months ended in . 20 was kr0.00 Mil. Therefore, Implantica AG's FCF Margin % for the quarter that ended in . 20 was 0.00%.

As of today, Implantica AG's current FCF Yield % is 0.00%.

The historical rank and industry rank for Implantica AG's FCF Margin % or its related term are showing as below:


OSTO:IMP A SDB's FCF Margin % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: -3.96
* Ranked among companies with meaningful FCF Margin % only.


Implantica AG FCF Margin % Historical Data

The historical data trend for Implantica AG's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Implantica AG FCF Margin % Chart

Implantica AG Annual Data
Trend
FCF Margin %

Implantica AG Semi-Annual Data
FCF Margin %

Competitive Comparison of Implantica AG's FCF Margin %

For the Medical Devices subindustry, Implantica AG's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Implantica AG's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Implantica AG's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Implantica AG's FCF Margin % falls into.



Implantica AG FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Implantica AG's FCF Margin for the fiscal year that ended in . 20 is calculated as

FCF Margin=Free Cash Flow (A: . 20 )/Revenue (A: . 20 )
=/
= %

Implantica AG's FCF Margin for the quarter that ended in . 20 is calculated as

FCF Margin=Free Cash Flow (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Implantica AG FCF Margin % Related Terms

Thank you for viewing the detailed overview of Implantica AG's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Implantica AG Business Description

Comparable Companies
Traded in Other Exchanges
Address
Aeulestrasse 45, Vaduz, LIE, 9490
Implantica AG is a medtech group providing effective care for serious health conditions and improving patients' quality of life by bringing advanced technology into the body. The therapies Implantica develops are based on implants that are medical devices inserted into the patient's body and are intended to remain in place permanently or semi-permanently, using electrical power provided by a battery. The company has developed a broad, patent-protected, product pipeline based partly on its two platform technologies. To bring advanced technology into the body, and adequate energy supply is required which would require very large batteries, so, Implantica has developed a wireless energising platform to supply energy to the body through intact skin.

Implantica AG Headlines

No Headlines